Andere Sprachen Exact Sciences Corporation

Aktien

590273

US30063P1057

EXAS

Biotechnologie

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 16.01.2026			% 5 Tage	Veränd. 1. Jan.
102.43 ^USD	+0.09%		+0.31%	+0.86%

12.01.	Mdxhealth meldet vorläufige Umsätze für das vierte Quartal und das Gesamtjahr 2025, gibt Umsatzprognose für 2026 bekannt und ändert Earnout-Bedingungen mit Exact Sciences	RE
08.01.	Quanterix ernennt Everett Cunningham zum Präsidenten und CEO	MT

Andere Sprachen

12.01.	Mdxhealth reports preliminary fourth quarter and full year 2025 revenues, issues 2026 revenue guidance, and amends earnout terms with Exact Sciences
08.01.	Quanterix Names Everett Cunningham President and CEO
08.01.	Quanterix Names Everett Cunningham President and CEO
31.12.	Tel Aviv University: TAU and Google Israel Launch New Three-Year Program to Advance Core AI Research
30.12.	Alert from law firm on Exact Sciences-Abbott deal withdrawn
18.12.	Exact Sciences : Announces First Participant Enrolled in the CRANE Study, a Multi-Cancer Early Detection Clinical Evaluation in Japan
12.12.	Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect MRD Test in Early Triple-Negative Breast Cancer at SABCS
11.12.	Exact Sciences, the NSABP Foundation, and the German Breast Group Present Results for the Oncodetect® MRD Test in Early Triple-Negative Breast Cancer at SABCS
11.12.	Exact Sciences Corp. Announces the First Clinical Study Results from Its Oncodetect Molecular Resistant Disease Test in Early Triple-Negative Breast Cancer
26.11.	Pacific Edge Limited Announces the Appointment of James Vaughn, R.Ph. into the New Role of Chief Commercial Officer, Effective on 1 December 2025
25.11.	Wall Street coincée dans sa mue permanente
25.11.	Wall Street Continues to Shift
25.11.	Analyst recommendations: Accenture, Dell, Estee Lauder, Applovin, Dupont de Nemours…
24.11.	Exact Sciences Reinforces International Leadership in Breast Cancer with Strong Presence at 2025 San Antonio Breast Cancer Symposium
24.11.	Exact Sciences Reinforces International Leadership in Breast Cancer with Strong Presence At 2025 San Antonio Breast Cancer Symposium
24.11.	EXAS Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Exact Sciences to Abbott Laboratories
22.11.	Exact Sciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS
21.11.	Wall Street : Même l'excellence ne suffit pas
21.11.	Still Not Enough
21.11.	Analyst recommendations: Block, Palo Alto Networks, Biogen, Moderna, Netflix…
20.11.	Health Care Down, But not by Much, Amid Deal Activity -- Health Care Roundup
20.11.	Sector Update: Health Care Stocks Softer Late Afternoon
20.11.	Top Midday Gainers
20.11.	Sector Update: Health Care Stocks Lower Thursday Afternoon
20.11.	Sector Update: Health Care

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen MarketScreener Artikel MarketScreener Analysen Trading-Ideen

Filter

Schlagzeilen

Exact Sciences CEO spricht über Einführung des neuen Multi-Krebs-Bluttests

Am 15. September 2025 um 17:32 Uhr